German car makers in South Africa are spending big money on anti-AIDS drugs, treatment and education to tackle the pandemic among their workforce, Reuters reported on Thursday.
Staying true to its motto, "HIV/AIDS Is Everybody's Business", Daimler Chrysler South Africa (DCSA) spends over US $420,000 annually to provide antiretroviral drugs to an estimated nine percent of its HIV-positive workforce.
DCSA said it hoped the programme would reduce costs related to lost production through absenteeism, the hiring and training of new workers, and claims on company insurance funds.
Mike Folan, the Group human resources manager for DCSA, said: We decided on giving antiretroviral drugs to our employees because of the government's policy at the time, [which] wasn't providing antiretroviral therapy."
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions